Camzyos fda approval date?

When was Camzyos (mavacamten) approved by the FDA?

Camzyos (mavacamten) received FDA approval on April 26, 2022. [1]

What does that date mean for patients and the market?

That approval date is when the FDA first allowed Camzyos to be marketed in the U.S. under its approved indication and label. After approval, the drug’s prescribing and reimbursement use could begin following standard payer and provider uptake processes.

Where can I verify the FDA approval date?

You can cross-check FDA approval timing using drug-tracking and patent-exclusivity resources such as DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/medicine/camzyos